The generation of NGF-secreting primary rat monocytes: A comparison of different transfer methods

Journal of Immunological Methods

Volumn 391, Issue 1-2, 2013, Pages 112-124

  Hohsfield, Lindsay A ^a   Geley, Stephan ^a   Reindl, Markus ^a   Humpel, Christian ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

NGF; Primary monocytes; Transduction; Transfection

Indexed keywords

AMYLOID BETA PROTEIN; LENTIVIRUS VECTOR; LIPID; NERVE GROWTH FACTOR;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BRAIN SLICE; CELL DIFFERENTIATION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ELECTROPORATION; GENE TRANSFER; GENETIC TRANSFECTION; MONOCYTE; NONHUMAN; NUCLEOFECTION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; ELECTROPORATION; GENETIC VECTORS; LENTIVIRUS; LIPIDS; MONOCYTES; NERVE GROWTH FACTOR; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; TRANSFECTION;

RATTUS;

EID: 84876139261     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2013.02.016     Document Type: Article

References (42)

1. Bhattacharjee A., Mishra R.S., Feldman G.M., Cathcart M.K. In vivo validation of signaling pathways regulating human monocyte chemotaxis. J. Immunol. Methods 2008, 330(1-2):86-95.
2. Böttger D., Ullrich C., Humpel C. Monocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell monolayer in vitro and counteract degeneration of cholinergic neurons. Brain Res. 2010, 1312:108-119.
3. Capsoni S., Covaceuszach S., Ugolini G., Spirito F., Vignone D., Stefanini B., Amato G., Cattaneo A. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J. Alzheimers Dis. 2009, 16(2):371-388.
4. Capsoni S., Tiveron C., Amato G., Vignone D., Cattaneo A. Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice. J. Alzheimers Dis. 2010, 20(2):527-546.
5. Covaceuszach S., Capsoni S., Ugolini G., Spirito F., Vignone D., Cattaneo A. Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr. Alzheimer Res. 2009, 6(2):158-170.
6. El Khoury J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., Luster A.D. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 2007, 13(4):432-438.
7. Fiala M., Zhang L., Gan X., Sherry B., Taub D., Graves M.C., Hama S., Way D., Weinand M., Witte M., Lorton D., Kuo Y.M., Roher A.E. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol. Med. 1998, 4(7):480-489.
8. Fiala M., Lin J., Ringman J., Kermani-Arab V., Tsao G., Patel A., Lossinsky A.S., Graves M.C., Gustavson A., Sayre J., Sofroni E., Suarez T., Chiappelli F., Bernard G. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J. Alzheimers Dis. 2005, 7(3):221-232.
9. Fortress A.M., Buhusi M., Helke K.L., Granholm A.E. Cholinergic degeneration and alterations in the TrkA and p75NTR balance as a result of pro-NGF injection into aged rats. J. Aging Res. 2011, (2011, Article ID 460543). 10.4061/2011/460543.
10. Gate D., Rezai-Zadeh K., Jodry D., Rentsendorj A., Town T. Macrophages in Alzheimer's disease: the blood-borne identity. J. Neural Transm. 2010, 117(8):961-970.
11. Giri R., Shen Y., Stins M., Du Yan S., Schmidt A.M., Stern D., Kim K.S., Zlokovic B., Kalra V.K. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 2000, 279(6):C1772-C1781.
12. Granholm A.C., Albeck D., Bäckman C., Curtis M., Ebendal T., Friden P., Henry M., Hoffer B., Kordower J., Rose G.M., Söderström S., Bartus R.T. A non-invasive system for delivering neural growth factors across the blood-brain barrier: a review. Rev. Neurosci. 1998, 9(1):31-55.
13. Gu H., Long D., Song C., Li X. Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion. Neurosci. Lett. 2009, 453(3):204-209.
14. Herold J., Tillmanns H., Xing Z., Strasser R.H., Braun-Dullaeus R.C. Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis. Langenbecks Arch. Surg. 2006, 391(2):72-82.
15. Hohsfield L.A., Humpel C. Homocysteine enhances transmigration of rat monocytes through a brain capillary endothelial cell monolayer via ICAM-1. Curr. Neurovasc. Res. 2010, 7(3):192-200.
16. Humpel C. Basolateral aggregated rat amyloid beta (1-42) potentiates transmigration of primary rat monocytes through a rat blood brain barrier. Curr. Neurovasc. Res. 2008, 5(3):185-192.
17. Humpel C., Weis C. Nerve growth factor and cholinergic CNS neurons studied in organotypic brain slices. Implication in Alzheimer's disease?. J. Neural Transm. Suppl. 2002, 62:253-263.
18. Kramer R., Zhang Y., Gehrmann J., Gold R., Thoenen H., Wekerle H. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nat. Med. 1995, 1(11):1162-1166.
19. Kurakhmaeva K.B., Djindjikhashvili I.A., Petrov V.E., Balabanyan V.U., Voronina T.A., Trofimov S.S., Kreuter J., Gelperina S., Begley D., Alyautdin R.N. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. J. Drug Target. 2009, 17(8):564-574.
20. Lebson L., Nash K., Kamath S., Herber D., Carty N., Lee D.C., Li Q., Szekeres K., Jinwal U., Koren J., Dickey C.A., Gottschall P.E., Morgan D., Gordon M.N. Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice. J. Neurosci. 2010, 30(29):9651-9658.
21. Magga J., Savchenko E., Malm T., Rolova T., Pollari E., Valonen P., Lehtonen S., Jantunen E., Aarnio J., Lehenkari P., Koistinaho M., Muona A., Koistinaho J. Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer'sdisease. J. Cell. Mol. Med. 2012, 16(5):1060-1073.
22. Malm T., Koistinaho M., Muona A., Magga J., Koistinaho J. The role and therapeutic potential of monocytic cells in Alzheimer's disease. Glia 2010, 58(8):889-900.
23. Mandel R.J., Burger C. Clinical trials in neurological disorders using AAV vectors: promises and challenges. Curr. Opin. Mol. Ther. 2004, 6(5):482-490.
24. Martinet W., Schrijvers D.M., Kockx M.M. Nucleofection as an efficient nonviral transfection method for human monocytic cells. Biotechnol. Lett. 2003, 25(13):1025-1029.
25. Mordelet E., Kissa K., Calvo C.F., Lebastard M., Milon G., van der Werf S., Vidal C., Charneau P. Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: an approach to complement brain dysfunctions. Gene Ther. 2002, 9(1):46-52.
26. Moser K.V., Humpel C. Primary rat monocytes migrate through a BCEC monolayer and express microglia markers at the basolateral side. Brain Res. Bull. 2007, 74(5):336-343.
27. Nagahara A.H., Merrill D.A., Coppola G., Tsukada S., Schroeder B.E., Shaked G.M., Wang L., Blesch A., Kim A., Conner J.M., Rockenstein E., Chao M.V., Koo E.H., Geschwind D., Masliah E., Chiba A.A., Tuszynski M.H. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat. Med. 2009, 15(3):331-337.
28. Rost B., Hanf G., Ohnemus U., Otto-Knapp R., Groneberg D.A., Kunkel G., Noga O. Monocytes of allergics and non-allergics produce, store and release the neurotrophins NGF, BDNF and NT-3. Regul. Pept. 2005, 124(1-3):19-25.
29. Schnoor M., Buers I., Sietmann A., Brodde M.F., Hofnagel O., Robenek H., Lorkowski S. Efficient non-viral transfection of THP-1 cells. J. Immunol. Methods 2009, 344(2):109-115.
30. Schwartz M., Shechter R. Systemic inflammatory cells fight off neurodegenerative disease. Nat. Rev. Neurol. 2010, 6:405-410.
31. Scriba A., Luciano L., Steiniger B. High-yield purification of rat monocytes by combined density gradient and immunomagnetic separation. J. Immunol. Methods 1996, 189(2):203-216.
32. Seiger A., Nordberg A., von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A., et al. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res. 1993, 57(2):255-261.
33. Shechter R., Schwartz M. Harnessing monocyte-derived macrophages to control central nervous system pathologies: no longer 'if' but 'how'. J. Pathol. 2013, 229(2):332-346.
34. Tuszynski M.H., Thal L., Pay M., Salmon D.P., U H.S., Bakay R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., Conner J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 2005, 11(5):551-555.
35. Weis C., Marksteiner J., Humpel C. Nerve growth factor and glial cell line-derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert. Neuroscience 2001, 102(1):129-138.
36. Whittemore S.R., Ebendal T., Lärkfors L., Olson L., Seiger A., Strömberg I., Persson H. Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc. Natl. Acad. Sci. U. S. A. 1986, 83(3):817-821.
37. Wiesenhofer B., Humpel C. Lipid-mediated gene transfer into primary neurons using FuGene: comparison to C6 glioma cells and primary glia. Exp. Neurol. 2000, 164(1):38-44.
38. Yamaguchi K., Inoue M., Goshima N. Efficent protein transduction method using cationic peptides and lipids. J. Biomed. Biotechnol. 2011, 2011:872065.
39. Zassler B., Humpel C. Transplantation of NGF secreting primary monocytes counteracts NMDA-induced cell death of rat cholinergic neurons in vivo. Exp. Neurol. 2006, 198(2):391-400.
40. Zassler B., Blasig I.E., Humpel C. Protein delivery of caspase-3 induces cell death in malignant C6 glioma, primary astrocytes and immortalized and primary brain capillary endothelial cells. J. Neurooncol. 2005, 71(2):127-134.
41. Zassler B., Dechant G., Humpel C. Urea enhances the nerve growth factor-induced neuroprotective effect on cholinergic neurons in organotypic rat brain slices. Neuroscience 2005, 130(2):317-323.
42. Zimmermann O., Homann J.M., Bangert A., Müller A.M., Hristov G., Goeser S., Wiehe J.M., Zittrich S., Rottbauer W., Torzewski J., Pfitzer G., Katus H.A., Kaya Z. Successful use of mRNA-nucleofection for overexpression of interleukin-10 in murine monocytes/macrophages for anti-inflammatory therapy in a murine model of autoimmune myocarditis. J. Am. Heart Assoc. 2012, 1(6):e003293.